Edgewise Therapeutics, Inc. (EWTX) delivered a return of 154.39% over the past year. Since EWTX does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Edgewise Therapeutics, Inc. one year ago would be worth $25,439 today, representing a gain of $15,439.

Edgewise Therapeutics, Inc. (EWTX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For EWTX, the total return equals the price-only return.

Yes, Edgewise Therapeutics, Inc. (EWTX) outperformed the S&P 500 by 129.40 percentage points over the past year. EWTX delivered a total return of 154.39%, compared to the S&P 500's 24.99%. This 129.40pp alpha means investors in EWTX earned more than a passive S&P 500 index fund.

Edgewise Therapeutics, Inc. (EWTX) experienced a maximum drawdown of -19.59% over the past year, declining from its peak on 2025-11-28 to its trough on 2025-12-22. The stock recovered to its prior peak by 2025-12-24. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Edgewise Therapeutics, Inc. (EWTX)'s long-term returns with dividends reinvested. Over 10 years, the total return is 22.7% (2.1% CAGR) — $10,000 would have grown to $12,270. Over 20 years: 22.7% total return (1.0% CAGR) — $10,000 → $12,270. Over 30 years: 22.7% total return (0.7% CAGR) — $10,000 → $12,270. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Edgewise Therapeutics, Inc.'s best calendar year was 2024 with a total return of 142.7%. Its worst year was 2021 with a total return of -49.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 191.8 percentage points.